Reterence List

1. Reilly JIG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTcinterval
abnormalities and psychotropic drug therapy in psychiatric patients. Lancet
2000; 355(9209):1048-1052.

2. Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vettermann J.
Droperidol causes a dose-dependent prolongation of the QT interval. Anesth
Analg 1994; 79(5):983-986.

3. Glassman AH, Bigger JT, Jr. Antipsychotic drugs: prolonged QTc interval,
torsade de pointes, and sudden death. Am J Psychiatry 2001, 158(11):1774-1782.

4. Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I et al.
The association between intravenous haloperidol and prolonged QT interval. J
Clin Psychopharmacol 2001; 21(3):257-261.

5. Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D. Interactions of the
5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac
ion channels. J Pharmacol Exp Ther 2000; 295(2):614-620.

6. Lawrence KR, Nasraway SA. Conduction disturbances associated with
administration of butyrophenone antipsychotics in the critically ill: a review
of the literature. Pharmacotherapy 1997; 17(3):531-537.

7. Woosley RL. Drugs that prolong the QT interval and/or induce Torsades de
Pointes. www.torsades.org . 2002. 5-25-0002. Ref Type: Electronic Citation

8. Young D. Black-box warning for droperidol surprises pharmacists. Am J
Health Syst Pharm 2002; 59(6):494, 497, 502.

9. Kuryshev YA, Brown AM, Wang L, Benedict CR, Rampe D. Interactions of the
5-Hydroxytryptamine 3 Antagonist Class of Antiemetic Drugs with Human Cardiac
Ion Channels. J Pharmacol Exp Ther 2000; 295(2):614-620.

10. GIaxoSmithKline. GIaxoSmithKline Annual Report 2001. 2002. Ref Type:
Report

11. Sales increases of Zofran 2002. 6-10-2002. Ref Type: Personal
Communication

12. Chen JJ, Frame DG, White TJ. Efficacy of ondansetron and prochlorperazine
for the prevention of postoperative nausea and vomiting after total hip
replacement or total knee replacement procedures: a randomized, double-blind,
comparative trial. Arch Intern Med 1998, 158(19):2124-2128.

13. Dabbous A, Khoury SJ, Chehab IR, Bartelmaos T, Khoury G. Ondansetron
versus dehydrobenzoperidol and metoclopramide for management of postoperative
nausea in laparoscopic surgery patients. JSLS 2001; 512):139-142.

14. Dornhoffer J, Manning L. Unplanned admissions following outpatient
otologic surgery: the University of Arkansas experience. Ear Nose Throat J
2000, 79(9):710, 713-710, 717.

15. Dresner M, Dean S, Lumb A, Bellamy M. High-dose ondansetron regimen vs
droperidol for morphine patientcontrolled analgesia. Br J Anaesth 1998,
81(3):384-386.

16. Fabling JIM, Gan TJ, El Moalem HE, Warner DS, Borel CO. A randomized,
double-blinded comparison of ondansetron, droperidol, and placebo for
prevention of postoperative nausea and vomiting after supratentorial
craniotomy. Anesth Analg 2000; 91(2):358-361.

17. Gilbert CJ, Petros WP, Vredenburgh J, Hussein A, Ross M, Rubin P et al.
Pharmacokinetic interaction between ondansetron and cyclophosphamide during
high-dose chemotherapy for breast cancer. Cancer Chemother Pharmacol 1998,
42(6):497-503.

18. Hill RP, Lubarsky DA, Phillips-Bute B, Fortney JT, Creed MR, Glass PS et
al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron,
droperidol, or placebo. Anesthesiology 2000, 92(4):958-967.

19. Kreisler NS, Spiekermann BF, Ascari CM, Rhyne HA, Kloth RL, Sullivan LM et
al. Small-dose droperidol effectively reduces nausea in a general surgical
adult patient population. Anesth Analg 2000, 91(5):1256-1261.

20. Lee TH, Lin CR, Lee TC, Buerkle H, Hsu TY, Mao CC et al Failure of
prevention against postoperative vomiting by ondansetron or prochlorperazine
in patients undergoing gynecological laparoscopy. Acta Anaesthesiol Sin 2000,
38(4)'201-205.

21. Levy E, Paillarse JM, Votan B. [Efficacy of ondansetron in
radiation-induced nausea and vomiting: review of the literature]. Bull Cancer
Radlother 1994, 81131:179-185.

22. Millo J, Siddons M, Innes R, Laurie PS. Randomised doubleblind comparison
of ondansetron and droperidol to prevent postoperative nausea and vomiting
associated with patientcontrolled analgesia Anaesthesia 2001, 56111:60-65.

23. Peixoto AJ, Peixoto Filho AJ, Leaes LF, Celich MF, Barros MA Efficacy of
prophylactic droperidol, ondansetron or both in the prevention of
postoperative nausea and vomiting in major gynaecological surgery. A
prospective, randomized, double-blind clinical trial. Eur J Anaesthesiol 2000;
17(10):611615.

24. Sharma S, Abdullah N. A comparison of commonly used antiemetics for the
prevention of emetic sequelae after a major gynaecological surgery Singapore
Med J 2000, 41(4):147150

25. van den Berg AA. Comparison of ondansetron and prochlorperazine for the
prevention of nausea and vomiting after adenotonsillectomy. Br J Anaesth 1996,
76(3) 449-451.

26. Cox F. Systematic review of ondansetron for the prevention and treatment
of postoperative nausea and vomiting in adults, Br J Theatre Nurs 1999,
9(12):556-63, 566.

27. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ. Impact of covert duplicate
publication on meta-analysis: a case study. BMJ 1997, 315(7109):635-640.

28. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH.
Timing of new black box warnings and withdrawals for prescription medications.
JAMA 2002, 287(17):2215-2220.

29. Horowitz BZ, et al. Droperidol - Behind the Black Box Warning, Acad.
Emerg. Med. June 2002, Vol. 9, No. 6, 615618.